NV1505 or PG1505 differentially regulated the respiratory innate antiviral immune response triggered by the activation of Toll-like receptor 3 (TLR3), improving the resistance to a primary RSV infection and secondary pneumococcal pneumonia. Here, TLR3 is linked to pneumococcal pneumonia.